US 8853397
2,4-pyrimidinediamine compounds and their uses
granted A61KA61K31/505A61K31/506
Quick answer
US patent 8853397 (2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/519, A61K31/5377